EUCLYD
EUCLYD is developing custom AI processors, memory architectures and data-centre systems designed to make large-scale AI inference more power- and cost-efficient.
>€200MSeries A
LeadActivity from announced rounds
Scaleup Europe Fund is the EQT-managed fund explicitly named in EUCLYD, Tandem and Mistral announcements.
EUCLYD develops processors and memory for inference. Tandem automates clinical documentation, while Mistral supplies models and computing infrastructure. This named fund remains separate from EQT Ventures, EIC Fund and earlier manager-level activity.
EUCLYD is developing custom AI processors, memory architectures and data-centre systems designed to make large-scale AI inference more power- and cost-efficient.
Tandem builds an AI clinical assistant that turns patient consultations and clinician dictation into draft notes and follow-up documents for review in existing medical-record systems.